trending Market Intelligence /marketintelligence/en/news-insights/trending/cjxusmyv5yeou5-jnb5-2w2 content esgSubNav
In This List

Bionomics CEO appointed Bioasis chair

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Bionomics CEO appointed Bioasis chair

Canadian biopharmaceutical company Bioasis Technologies Inc. appointed Deborah Rathjen to be the chair of its board.

Rathjen takes over from former board chair and CEO Rob Hutchison, who retired Dec. 4, 2017.

Rathjen is the CEO and managing director of Bionomics Ltd.